Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Correction: DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S delivers annual shareholder letter and investor update
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Flagging announcement
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1